Logo
Logo

About Mirabegron (Alpha) API

Product
  • Therapeutic CategoryUrology

  • API Technology

    Synthetic

  • Dose Form

    ER Tablets

  • Dr Reddy's Development Status

    Available (Commercial)

  • Available Regulatory Filing

    USDMF, Brazil DMF, EUDMF, Canada DMF, Korea DMF, China DMF, CEP Submitted

Mechanism of Action

Mirabegron is an agonist of the human beta-3 adrenergic receptor (AR) as demonstrated by in vitro laboratory experiments using the cloned human beta-3 AR. Mirabegron relaxes the detrusor smooth muscle during the storage phase of the urinary bladder fill-void cycle by activation of beta-3 AR which increases bladder capacity. Although mirabegron showed very low intrinsic activity for cloned human beta-1 AR and beta-2 AR, results in humans indicate that beta-1 AR stimulation occurred at a mirabegron dose of 200 mg.

Indication

MYRBETRIQ is a beta-3 adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.

MYRBETRIQ, in combination with the muscarinic antagonist solifenacin succinate, is indicated for the treatment of OAB with symptoms of urge urinary incontinence, urgency, and urinary frequency

Dr. Reddy's Expertise

Headquartered in Hyderabad, India, Dr. Reddy's Laboratories is one of the leading Active Pharmaceutical Ingredients (API) manufacturers and suppliers globally for Mirabegron (Alpha) API. Dr. Reddy's API business is a preferred partner to pharma companies across the US, Europe, Brazil, Latin America, Japan, China, Korea, Middle East and other emerging markets.

Dr. Reddy's API business thrives on the deep technical strengths established over the last 30+ years in the development and manufacture of complex APIs such as steroids, peptides, complex long chain molecules and highly potent APIs (HPAPIs / oncology drugs). This expertise is complemented by our prowess in intellectual property and regulatory affairs which helps us consistently meet and exceed regulatory standards. Dr. Reddy's Mirabegron (Alpha) API is the outcome of the extensive expertise in R&D, IP, and Regulatory.

A key component in helping our customers be first to market is a responsive supply chain. We achieve this by making sure that all our facilities are operating efficiently and to the latest standards of quality, safety, and productivity. A strong interconnect between business and factories allows for a quick reaction to dynamic market changes, so that we can avert shortages and meet sudden surges in demand.

 

Dr. Reddy's provides access to mirabegron API at competitive prices. We are a leading manufacturer of mirabegron, ensuring consistent quality and reliable supply for your pharmaceutical formulations. To know more about Mirabegron price please contact us at [email protected]

RFQ Form

Phone

Related Resources

Description not provided

FAQs

What is Mirabegron (Alpha) API used for?
  • Treats overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency

What are the benefits of Mirabegron (Alpha) API?
  • Increases bladder capacity
    Reduces urgency and frequency of urination
    Improves quality of life for OAB patients

What is the safety guide for Mirabegron (Alpha) API?
  • Monitor blood pressure regularly
    Avoid in patients with severe uncontrolled hypertension
    Use protective equipment when handling

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.